KDR and breast cancer: The expression of VEGFA is not affected by the −460 T/C, −2578 C/A, and −2549 I/D SNPs, and high expression of VEGFA and its receptor, VEGFR2, are significantly associated with BC staging, suggesting that they can be used as promising biomarkers for BC diagnosis.